Covered recipient · General Payments record
ANNA WNUK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$257.82
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $257.82 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $162.06 | 12 |
| Lilly USA, LLC | $37.67 | 2 |
| Biogen, Inc. | $22.77 | 1 |
| IBSA Pharma Inc. | $18.17 | 1 |
| Kowa Pharmaceuticals America, Inc. | $17.15 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $257.82 | 17 |
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Biogen, Inc. | $22.77 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104841578 | CMS |
| IBSA Pharma Inc. | $18.17 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142975333 | CMS |
| Kowa Pharmaceuticals America, Inc. | $17.15 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113475255 | CMS |
| Lilly USA, LLC | $16.59 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135514474 | CMS |
| Lilly USA, LLC | $21.08 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135529858 | CMS |
| Novo Nordisk Inc | $6.66 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100405203 | CMS |
| Novo Nordisk Inc | $3.63 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100253238 | CMS |
| Novo Nordisk Inc | $3.40 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100438519 | CMS |
| Novo Nordisk Inc | $7.91 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100245557 | CMS |
| Novo Nordisk Inc | $6.66 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100543088 | CMS |
| Novo Nordisk Inc | $20.83 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100457826 | CMS |
| Novo Nordisk Inc | $19.56 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100520411 | CMS |
| Novo Nordisk Inc | $20.70 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100260195 | CMS |
| Novo Nordisk Inc | $20.04 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100540542 | CMS |
| Novo Nordisk Inc | $19.21 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100565826 | CMS |
| Novo Nordisk Inc | $15.78 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100232088 | CMS |
| Novo Nordisk Inc | $17.68 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100287538 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.